News & Updates

Show Multimedia Only

Ipilimumab plus nivolumab elicits response in patients with rare cancer

Combination treatment with ipilimumab and nivolumab yields meaningful response among patients with multiple refractory rare cancer types, according to a phase II trial.

Ipilimumab plus nivolumab elicits response in patients with rare cancer

13 hours ago

Updated PREDICT model identifies low-risk TNBC patients who can skip chemo

a day ago

The addition of stromal tumour-infiltrating lymphocytes (sTILs) to the PREDICT prognostic model further improves decision-making regarding chemotherapy for early-stage patients with triple-negative breast cancer (TNBC), particularly in identifying those at low risk who may safely waive chemotherapy, according to a study.

Updated PREDICT model identifies low-risk TNBC patients who can skip chemo

a day ago

Mat Pilates, belly dance benefit women with breast cancer

08 Aug 2026

In women receiving hormone therapy for breast cancer, both mat Pilates and belly dance can help improve cardiorespiratory fitness and body composition, as shown in a study.

Mat Pilates, belly dance benefit women with breast cancer

08 Aug 2026

Vaginal tamoxifen beneficial to postmenopausal women

08 Aug 2026

In postmenopausal women with or without breast cancer, once-weekly treatment with vaginal tamoxifen helps reduce anxiety symptoms and relieve pain, as shown in a study.

Vaginal tamoxifen beneficial to postmenopausal women

08 Aug 2026

Interruptions in chemotherapy does not cut survival in patients with cervical cancer

07 Aug 2026

Intercycle delays in first-line systemic chemotherapy do not appear to negatively affect survival among patients with metastatic or recurrent cervical cancer, reveals a study.

Interruptions in chemotherapy does not cut survival in patients with cervical cancer

07 Aug 2026

Gender differences persist in CRC screening uptake in Singapore

06 Aug 2026 by

Men and women differ in terms of colorectal cancer (CRC) symptom awareness, perceived barriers to screening, and screening adherence, according to local research.

Gender differences persist in CRC screening uptake in Singapore

06 Aug 2026

Mezigdomide plus carfilzomib-dexamethasone confers survival benefit in RRMM

06 Aug 2026 by

Treatment with mezigdomide (Mezi) plus carfilzomib and dexamethasone (Kd) significantly improves progression-free survival (PFS) in patients with relapsed or refractory multiple myeloma (RRMM) compared with Kd regimen only, according to the phase III SUCCESSOR-2 trial presented at EHA 2026.

Mezigdomide plus carfilzomib-dexamethasone confers survival benefit in RRMM

06 Aug 2026

Noninvasive UGN-102 therapy delivers durable response in recurrent LG-IR-NMIBC

05 Aug 2026 by

Patients with recurrent low-grade intermediate-risk nonmuscle-invasive bladder cancer (LG-IR-NMIBC) who achieved an initial complete response (CR) to UGN-102 treatment tend to remain event-free 24 months later, according to phase III ENVISION trial.

Noninvasive UGN-102 therapy delivers durable response in recurrent LG-IR-NMIBC

05 Aug 2026

Ceralasertib plus durvalumab yields low response rates in immunotherapy-resistant melanoma

03 Aug 2026

In the treatment of patients with anti–PD-(L)1–resistant advanced melanoma, response with ceralasertib plus durvalumab is low, according to the phase II MONETTE study.

Ceralasertib plus durvalumab yields low response rates in immunotherapy-resistant melanoma

03 Aug 2026

High-dose vitamin D helps with severe cutaneous toxic effects of chemo, radiation

03 Aug 2026

High-dose vitamin D shows promise in the treatment of toxic erythema of chemotherapy (TEC) and acute radiation dermatitis (ARD), according to a retrospective study.

High-dose vitamin D helps with severe cutaneous toxic effects of chemo, radiation

03 Aug 2026

News & Updates

Showing Oncology articles

Showing

Specialty:

Ipilimumab plus nivolumab elicits response in patients with rare cancer

Ipilimumab plus nivolumab elicits response in patients with rare cancer

Updated PREDICT model identifies low-risk TNBC patients who can skip chemo

Updated PREDICT model identifies low-risk TNBC patients who can skip chemo

Mat Pilates, belly dance benefit women with breast cancer

Mat Pilates, belly dance benefit women with breast cancer

Vaginal tamoxifen beneficial to postmenopausal women

Vaginal tamoxifen beneficial to postmenopausal women

Interruptions in chemotherapy does not cut survival in patients with cervical cancer

Interruptions in chemotherapy does not cut survival in patients with cervical cancer

Gender differences persist in CRC screening uptake in Singapore

Gender differences persist in CRC screening uptake in Singapore

Mezigdomide plus carfilzomib-dexamethasone confers survival benefit in RRMM

Mezigdomide plus carfilzomib-dexamethasone confers survival benefit in RRMM

Noninvasive UGN-102 therapy delivers durable response in recurrent LG-IR-NMIBC

Noninvasive UGN-102 therapy delivers durable response in recurrent LG-IR-NMIBC

Ceralasertib plus durvalumab yields low response rates in immunotherapy-resistant melanoma

Ceralasertib plus durvalumab yields low response rates in immunotherapy-resistant melanoma

High-dose vitamin D helps with severe cutaneous toxic effects of chemo, radiation

High-dose vitamin D helps with severe cutaneous toxic effects of chemo, radiation